| Title | Onkológia
|
|---|
| Year, No. | Roč. 13, č. 3, rok 2018
|
|---|
| ISSN | 1336-8176
|
|---|
| Issue data | Bratislava : SOLEN, 2018
|
|---|
| Phys.des. | s. 157-226
|
|---|
| Collective Record/Entry | Onkológia
|
|---|
|
|
|---|
| Language | Slovak
|
|---|
| Country | Slovakia
|
|---|
| Copy count | 2, currently available 0, at library only 2
|
|---|
| Database | PERIODIKÁ - Prijaté čísla
|
|---|
| Content | Očkovanie onkologických pacientov : ktorí pacienti, aké vakcíny a kedy? / / Peter Beržinec
|
|---|
| Global cancer control: responding to the growing burden, rising costs and inequalities in access / / Bystricky B. ... [et al.]
|
|---|
| Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin.. / Vranovsky A. ... [et al.]
|
|---|
| NSCLC molecular testing in Central and Eastern European countries / / Berzinec P. ... [et al.]
|
|---|
| Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for.. / Sufliarsky J. ... [et al.]
|
|---|
| Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene.. / Sufliarsky J. ... [et al.]
|
|---|
| Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and.. / Šufliarsky J. ... [et al.]
|
|---|
| Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH / / Kolenová A. ... [et al.]
|
|---|
| ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an.. / Drgoňa L. ... [et al.]
|
|---|
| ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an.. / Drgoňa L. ... [et al.]
|
|---|
| Long-term cognitive functioning in testicular germ-cell tumor survivors / / Chovanec M. ... [et al.]
|
|---|
| Systemic immune-inflammation index in germ-cell tumours / / Chovanec M. ... [et al.]
|
|---|
| Immune-related concepts in biology and treatment of germ-cell tumors / / Chovanec M., De Giorgi U., Mego M.
|
|---|
| Daratumumab v kombinovanej liečbe mnohopočetného myelómu = Daratumumab combination therapy for multiple myeloma / / Ľubica Harvanová, Martin Mistrík,..
|
|---|
| Ivan Humeník, Patrik Palacka, Rudolf Straka, Vladimír Volčko: Vybrané právne problémy lekárov : otázky a odpovede / / Tomáš Šálek, Stanislav Špánik
|
|---|
| Olaratumab - liečba pre pacientov s pokročilým sarkónom mäkkých tkanív nevhodných na chirurgickú liečbu alebo rádioterapiu = Olaratumab - treatment in patients with.. / Peter Zuzák
|
|---|
| Úskalia diagnostiky uzlinového syndrómu na onkohematologickej ambulancii - kazuistika = The difficulties of lymph node syndrome diagnostics - case report / / Iveta Oravcová ... [et al.]
|
|---|
| FLT3 mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby = FLT3 mutations in AML: incidence, diagnostics options and its impact on.. / Eva Mikušková ... [et al.]
|
|---|
| Gravidita po onkologickej liečbe = Pregnancy after cancer treatment / / Katarína Rejleková
|
|---|
| Polycytémia vera - súčasný pohľad na diagnostiku a liečbu = Polycythemia vera - current view of diagnostics and treatment / / Antónia Hatalová ... [et al.]
|
|---|
| Zriedkavé nádory gastrointestinálneho systému s akcentom na análny karcinóm = Race cancers of gastrointestinal system with an accent on anal cancer / / Tomáš Šálek
|
|---|
| Extragonadálne germinatívne nádory = Extragonadal germ cell tumors / / Michal Chovanec
|
|---|
| Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm = A rare thorax tumor - malignant pleural mesothelioma / / Lucia Denková, František Sándor
|
|---|
| Zriedkavé epitelové nádory prsníka = Rare epithelial breast cancers / / Mária Rečková
|
|---|
